Pimozide versus chlorpromazine in chronic schizophrenia: a 52 week double-blind study of maintenance therapy
Wilson, L.G.; Roberts, R.W.; Gerber, C.J.; Johnson, M.H.
Journal of Clinical Psychiatry 43(2): 62-65
1982
ISSN/ISBN: 0160-6689 PMID: 7035441 Document Number: 184148
This study compared the effectiveness and safety of pimozide and chlorpromazine in the maintenance therapy of chronic schizophrenic outpatients. Forty-three patients were assigned in double-blind fashion to one of the drugs for the 52 week study. Both medication groups showed a general pattern of improvement over the course of the study, but there was no significant difference between the two groups. The results demonstrated the effectiveness and safety of pimozide in once daily administration. Previous research results showing the special utility of pimozide for the improvement of emotional withdrawal and social competence in schizophrenia were not replicated.